The first ‘blueprint’ of human skeletal development reveals how the skeleton forms, shedding light on the process of arthritis, and highlighting cells involved in conditions that affect skull and bone growth.
Bavarian Nordic drops cancer vaccine efforts to focus on infectious diseases
Bavarian Nordic will no longer work on its immuno-oncology vaccine program to instead focus on infectious disease R&D, with the company’s “record” 2023 sales buoyed